1. Academic Validation
  2. Effect of endothelin-1 (1-31) on human mesangial cell proliferation

Effect of endothelin-1 (1-31) on human mesangial cell proliferation

  • Jpn J Pharmacol. 2000 Oct;84(2):146-55. doi: 10.1254/jjp.84.146.
M Yoshizumi 1 S Kagami Y Suzaki K Tsuchiya H Houchi T Hisayama H Fukui T Tamaki
Affiliations

Affiliation

  • 1 Department of Pharmacology, The University of Tokushima School of Medicine, Japan.
Abstract

It was previously found that human chymase cleaves big endothelins (ETs) at the Tyr31-Gly32 bond and produces 31-amino acid ETs (1-31). In the present study, human plasma concentrations of ET-1 (1-31) and ET-1 were examined and the effect of synthetic ET-1 (1-31) on the proliferation of cultured human mesangial cells (HMCs) was investigated. The proliferative effect of ET-1 (1-31) was evaluated from the [3H]-thymidine uptake. The activity of extracellular signal-regulated kinase (ERK) and DNA binding activity of activator protein-1 were determined by using an in-gel kinase assay and gel mobility shift assay, respectively. Immunoreactive ET-1 (1-31) was detectable in plasma, but the level was slightly lower than that of ET-1. ET-1 (1-31) increased [3H]-thymidine incorporation in HMCs to a degree similar to that induced by ET-1. ET-1 (1-31) also activated ERK1/2. Inhibition of protein kinase C and ERK kinase caused a reduction of ET-1 (1-31)-induced ERK1/2 activation. The ERK1/2 activation was followed by an increase in transcription factor activator protein-1 DNA binding activity. These findings suggest that ET-1 (1-31) is a bioactive peptide in humans and ET-1 (1-31) itself stimulates HMC proliferation.

Figures
Products